Skip to main content

Lucigen Receives $2.5M SBIR Phase II Grant to Build Metagenomic DNA Libraries

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Lucigen today announced a $2.5 million grant from the National Institutes of Health to develop metagenomic DNA libraries for the identification of new antimicrobial and other anti-infective drug candidates.

The Small Business Innovation Research Phase II grant is the largest such grant that the Middleton, Wis.-based firm has ever received, it said, and will be used to create large metagenomic libraries for screening antimicrobial activity against four multiple drug-resistant pathogens.

Lucigen is partnering with Auburn University and the University of Mississippi on the project. In an earlier Phase I grant, Lucigen and Auburn used metagenomics to create a DNA library from soil microbes. The research led to 28 new compounds that inhibit the growth of methicillin-resistant Staphylococcus aureus.

Each year more than 100,000 Americans die from untreatable microbial infections, most of which are resistant to drugs. Lucigen said that the natural environment, particularly soils, which have a great diversity of microbial life, represent a promising source "for new antibiotic structures with potentially novel mechanisms of action."

With the new grant, Lucigen hopes to discover hundreds of new chemical entities which may lead to new drug candidates with "high potency against multiple bacterial pathogens." The drug candidates would be assessed for effectiveness using a novel in vivo MRSA assay.

The libraries also would be a valuable resource for screening bioactive compounds for potential use against other medical conditions such as cancer, viruses, and fungi, Lucigen said.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.